CD36 plays an important role in the clearance of oxLDL and associated age-dependent sub-retinal deposits

Aging

Volumn 2, Issue 12, 2010, Pages 981-989

  Picard, Emilie ^a   Houssier, Marianne ^b,c,d   Bujold, Kim ^e   Sapieha, Przemyslaw ^a   Lubell, William ^e   Dorfman, Allison ^f   Racine, Julie ^f   Hardy, Pierre ^a   Febbraio, Maria ^g   Lachapelle, Pierre ^f   Ong, Huy ^e   Sennlaub, Florian ^b,c,d,h   Chemtob, Sylvain ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b INSERM   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g LERNER RESEARCH INSTITUTE   (United States)

^h HÔTEL DIEU   (France)

Author keywords

Age related macular degeneration; Bruch's membrane; Cd36; Oxidized lipids

Indexed keywords

APOLIPOPROTEIN E; CD36 ANTIGEN; EP80317; LOW DENSITY LIPOPROTEIN; OLIGOPEPTIDE; OXIDIZED LOW DENSITY LIPOPROTEIN;

AGE; AGING; ANIMAL; ARTICLE; BRUCH MEMBRANE; CELL CULTURE; DISEASE MODEL; DRUG EFFECT; FAT INTAKE; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PIGMENT EPITHELIUM; RETINA MACULA DEGENERATION;

AGE FACTORS; AGING; ANIMALS; ANTIGENS, CD36; APOLIPOPROTEINS E; BRUCH MEMBRANE; CELLS, CULTURED; DIETARY FATS; DISEASE MODELS, ANIMAL; LIPOPROTEINS, LDL; MACULAR DEGENERATION; MICE; MICE, KNOCKOUT; OLIGOPEPTIDES; RETINAL PIGMENT EPITHELIUM;

EID: 79952266367     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100218     Document Type: Article

References (56)

1. Friedman DS, BJ O'Colmain, B Munoz, SC Tomany, C McCarty, PT de Jong, B Nemesure, P Mitchell and J Kempen. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004; 122: 564-572.
2. Green WR and C Enger. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman Lecture. Ophthalmology. 1993; 100: 1519-1535.
3. Sarks SH. Ageing and degeneration in the macular region: a clinico-pathological study. Br J Ophthalmol. 1976; 60: 324-341.
4. Lewis H, BR Straatsma and RY Foos. Chorioretinal juncture. Multiple extramacular drusen. Ophthalmology. 1986; 93: 1098-1112.
5. Zhao J, DA Frambach, PP Lee, M Lee and PF Lopez. Delayed macular choriocapillary circulation in age-related macular degeneration. Int Ophthalmol. 1995; 19: 1-12.
6. Li CM, BH Chung, JB Presley, G Malek, X Zhang, N Dashti, L Li, J Chen, K Bradley, HS Kruth and CA Curcio. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Invest Ophthalmol Vis Sci. 2005; 46: 2576-2586.
7. Pauleikhoff D, CA Harper, J Marshall and AC Bird. Aging changes in Bruch's membrane. A histochemical and morphologic study. Ophthalmology. 1990; 97: 171-178.
8. Curcio CA, CL Millican, T Bailey and HS Kruth. Accumulation of cholesterol with age in human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001; 42: 265-274.
9. Huang JD, JB Presley, MF Chimento, CA Curcio and M Johnson. Age-related changes in human macular Bruch's membrane as seen by quick-freeze/deep-etch. Exp Eye Res. 2007; 85: 202-218.
10. Sheraidah G, R Steinmetz, J Maguire, D Pauleikhoff, J Marshall and AC Bird. Correlation between lipids extracted from Bruch's membrane and age. Ophthalmology. 1993; 100: 47-51.
11. Huang JD, CA Curcio and M Johnson. Morphometric analysis of lipoprotein-like particle accumulation in aging human macular Bruch's membrane. Invest Ophthalmol Vis Sci. 2008; 49: 2721-2727.
12. Ishida BY, KG Duncan, KR Bailey, JP Kane and DM Schwartz. High density lipoprotein mediated lipid efflux from retinal pigment epithelial cells in culture. Br J Ophthalmol. 2006; 90: 616-620.
13. Holz FG, G Sheraidah, D Pauleikhoff and AC Bird. Analysis of lipid deposits extracted from human macular and peripheral Bruch's membrane. Arch Ophthalmol. 1994; 112: 402-406.
14. Tserentsoodol N, J Sztein, M Campos, NV Gordiyenko, RN Fariss, JW Lee, SJ Fliesler and IR Rodriguez. Uptake of cholesterol by the retina occurs primarily via a low density lipoprotein receptor-mediated process. Mol Vis. 2006; 12: 1306-1318.
15. Gordiyenko N, M Campos, JW Lee, RN Fariss, J Sztein and IR Rodriguez. RPE cells internalize low-density lipoprotein (LDL) and oxidized LDL (oxLDL) in large quantities in vitro and in vivo. Invest Ophthalmol Vis Sci. 2004; 45: 2822-2829.
16. Wang L, CM Li, M Rudolf, OV Belyaeva, BH Chung, JD Messinger, NY Kedishvili and CA Curcio. Lipoprotein particles of intraocular origin in human Bruch membrane: an unusual lipid profile. Invest Ophthalmol Vis Sci. 2009; 50: 870-877.
17. Johnson PT, MN Brown, BC Pulliam, DH Anderson and LV Johnson. Synaptic pathology, altered gene expression, and degeneration in photoreceptors impacted by drusen. Invest Ophthalmol Vis Sci. 2005; 46: 4788-4795.
18. Rodriguez IR, S Alam and JW Lee. Cytotoxicity of oxidized low-density lipoprotein in cultured RPE cells is dependent on the formation of 7-ketocholesterol. Invest Ophthalmol Vis Sci. 2004; 45: 2830-2837.
19. Dithmar S, CA Curcio, NA Le, S Brown and HE Grossniklaus. Ultrastructural changes in Bruch's membrane of apolipoprotein Edeficient mice. Invest Ophthalmol Vis Sci. 2000; 41: 2035-2042.
20. Fraser GE. Diet and coronary heart disease: beyond dietary fats and low-density-lipoprotein cholesterol. Am J Clin Nutr. 1994; 59: 1117S-1123S.
21. Ishigaki Y, H Katagiri, J Gao, T Yamada, J Imai, K Uno, Y Hasegawa, K Kaneko, T Ogihara, H Ishihara, Y Sato, K Takikawa, N Nishimichi, H Matsuda, T Sawamura and Y Oka. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis. Circulation. 2008; 118: 75-83.
22. Trivino A, AI Ramirez, JJ Salazar, R de Hoz, B Rojas, E Padilla, T Tejerina and JM Ramirez. A cholesterol-enriched diet induces ultrastructural changes in retinal and macroglial rabbit cells. Exp Eye Res. 2006; 83: 357-366.
23. Rudolf M, B Ivandic, J Winkler and U Schmidt-Erfurth. [Accumulation of lipid particles in Bruch's membrane of LDL receptor knockout mice as a model of age-related macular degeneration]. Ophthalmologe. 2004; 101: 715-719.
24. Ong JM, NC Zorapapel, KA Rich, RE Wagstaff, RW Lambert, SE Rosenberg, F Moghaddas, A Pirouzmanesh, AM Aoki and MC Kenney. Effects of cholesterol and apolipoprotein E on retinal abnormalities in ApoE-deficient mice. Invest Ophthalmol Vis Sci. 2001; 42: 1891-1900.
25. Ong JM, NC Zorapapel, AM Aoki, DJ Brown, AB Nesburn, KA Rich and CM Kenney. Impaired electroretinogram (ERG) response in apolipoprotein E-deficient mice. Curr Eye Res. 2003; 27: 15-24.
26. Parekh N, RP Voland, SM Moeller, BA Blodi, C Ritenbaugh, RJ Chappell, RB Wallace and JA Mares. Association between dietary fat intake and age-related macular degeneration in the Carotenoids in Age-Related Eye Disease Study (CAREDS): an ancillary study of the Women's Health Initiative. Arch Ophthalmol. 2009; 127: 1483-1493.
27. Duncan KG, KR Bailey, JP Kane and DM Schwartz. Human retinal pigment epithelial cells express scavenger receptors BI and BII. Biochem Biophys Res Commun. 2002; 292: 1017-1022.
28. Ryeom SW, JR Sparrow and RL Silverstein. CD36 participates in the phagocytosis of rod outer segments by retinal pigment epithelium. J Cell Sci. 1996; 109 (Pt 2): 387-395.
29. Endemann G, LW Stanton, KS Madden, CM Bryant, RT White and AA Protter. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993; 268: 11811-11816.
30. Febbraio M, NA Abumrad, DP Hajjar, K Sharma, W Cheng, SF Pearce and RL Silverstein. A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J Biol Chem. 1999; 274: 19055-19062.
31. Collot-Teixeira S, J Martin, C McDermott-Roe, R Poston and JL McGregor. CD36 and macrophages in atherosclerosis. Cardiovasc Res. 2007; 75: 468-477.
32. Houssier M, W Raoul, S Lavalette, N Keller, X Guillonneau, B Baragatti, L Jonet, JC Jeanny, F Behar-Cohen, F Coceani, D Scherman, P Lachapelle, H Ong, S Chemtob and F Sennlaub. CD36 deficiency leads to choroidal involution via COX2 downregulation in rodents. PLoS Med. 2008; 5: e39.
33. Kunjathoor VV, M Febbraio, EA Podrez, KJ Moore, L Andersson, S Koehn, JS Rhee, R Silverstein, HF Hoff and MW Freeman. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem. 2002; 277: 49982-49988.
34. Kondo N, S Honda, S Kuno and A Negi. Positive association of common variants in CD36 with neovascular age-related macular degeneration. Aging. 2009; 1: 266-274.
35. Febbraio M, EA Podrez, JD Smith, DP Hajjar, SL Hazen, HF Hoff, K Sharma and RL Silverstein. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest. 2000; 105: 1049-1056.
36. Marleau S, D Harb, K Bujold, R Avallone, K Iken, Y Wang, A Demers, MG Sirois, M Febbraio, RL Silverstein, A Tremblay and H Ong. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. FASEB J. 2005; 19: 1869-1871.
37. Dembinska O, LM Rojas, S Chemtob and P Lachapelle. Evidence for a brief period of enhanced oxygen susceptibility in the rat model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci. 2002; 43: 2481-2490.
38. Dembinska O, LM Rojas, DR Varma, S Chemtob and P Lachapelle. Graded contribution of retinal maturation to the development of oxygen-induced retinopathy in rats. Invest Ophthalmol Vis Sci. 2001; 42: 1111-1118.
39. Dorfman AL, O Dembinska, S Chemtob and P Lachapelle. Structural and functional consequences of trolox C treatment in the rat model of postnatal hyperoxia. Invest Ophthalmol Vis Sci. 2006; 47: 1101-1108.
40. Nakamura YK and ST Omaye. Age-related changes of serum lipoprotein oxidation in rats. Life Sci. 2004; 74: 1265-1275.
41. Ruberti JW, CA Curcio, CL Millican, BP Menco, JD Huang and M Johnson. Quick-freeze/deep-etch visualization of age-related lipid accumulation in Bruch's membrane. Invest Ophthalmol Vis Sci. 2003; 44: 1753-1759.
42. Kamei M, K Yoneda, N Kume, M Suzuki, H Itabe, K Matsuda, T Shimaoka, M Minami, S Yonehara, T Kita and S Kinoshita. Scavenger receptors for oxidized lipoprotein in age-related macular degeneration. Invest Ophthalmol Vis Sci. 2007; 48: 1801-1807.
43. Wang L, ME Clark, DK Crossman, K Kojima, JD Messinger, JA Mobley and CA Curcio. Abundant lipid and protein components of drusen. PLoS One. 2010; 5: e10329.
44. Saint-Geniez M, T Kurihara, E Sekiyama, AE Maldonado and PA D'Amore. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci U S A. 2009; 106: 18751-18756.
45. Moore DJ, AA Hussain and J Marshall. Age-related variation in the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci. 1995; 36: 1290-1297.
46. Starita C, AA Hussain, S Pagliarini and J Marshall. Hydrodynamics of ageing Bruch's membrane: implications for macular disease. Exp Eye Res. 1996; 62: 565-572.
47. Johnson LV, WP Leitner, AJ Rivest, MK Staples, MJ Radeke and DH Anderson. The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A. 2002; 99: 11830-11835.
48. Anderson DH, KC Talaga, AJ Rivest, E Barron, GS Hageman and LV Johnson. Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. Exp Eye Res. 2004; 78: 243-256.
49. Li CM, ME Clark, M Rudolf and CA Curcio. Distribution and composition of esterified and unesterified cholesterol in extramacular drusen. Exp Eye Res. 2007; 85: 192-201.
50. Malek G, CM Li, C Guidry, NE Medeiros and CA Curcio. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. Am J Pathol. 2003; 162: 413-425.
51. Anderson DH, S Ozaki, M Nealon, J Neitz, RF Mullins, GS Hageman and LV Johnson. Local cellular sources of apolipoprotein E in the human retina and retinal pigmented epithelium: implications for the process of drusen formation. Am J Ophthalmol. 2001; 131: 767-781.
52. Klaver CC, M Kliffen, CM van Duijn, A Hofman, M Cruts, DE Grobbee, C van Broeckhoven and PT de Jong. Genetic association of apolipoprotein E with age-related macular degeneration. Am J Hum Genet. 1998; 63: 200-206.
53. Li CM, ME Clark, MF Chimento and CA Curcio. Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression. Invest Ophthalmol Vis Sci. 2006; 47: 3119¬3128.
54. Guymer RH and EW Chong. Modifiable risk factors for agerelated macular degeneration. Med J Aust. 2006; 184: 455-458.
55. Dasch B, A Fuhs, A Meister, T Behrens, K Krause, D Pauleikhoff and HW Hense. [Association between classic cardiovascular risk factors and age-related maculopathy (ARM). Results of the baseline examination of the Munster Aging and Retina Study (MARS)]. Ophthalmologe. 2005; 102: 1057-1063.
56. Tomany SC, JJ Wang, R Van Leeuwen, R Klein, P Mitchell, JR Vingerling, BE Klein, W Smith and PT De Jong. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology. 2004; 111: 1280-1287.